Abbott India has announced impressive financial results for the third quarter of FY25, reporting a revenue of ₹16.14 billion from operations. The company's profit after tax reached ₹3.61 billion, reflecting robust performance amid a challenging market environment. This growth underscores Abbott's resilience and strategic positioning within the pharmaceutical sector, contributing positively to its overall financial health. As the earnings season progresses, Abbott's results stand out among key players in the industry.
Source: Financial Express.